Following a shift in its business model from developing proprietary pain therapy products to pure contract research, Algos Therapeutics has changed its name to Algos Preclinical Services. The company's new tagline, "Expertise in pain. Legendary service. Definitive results. For better quality of life." reinforces its repositioning as the go-to-CRO (Contract Research Organization) for drug discovery and product development.
Serving customers from Big Pharma to the biotech sectors, Algos Preclinical Services provides a wide range of services for companies seeking to contract preclinical pharmacology and physiology testing. The company's expertise in pain research, combined with a customer-centric approach, and dependable, definitive results make them an ideal partner for pharma and device companies with pain treatment programs.
Algos' transformation is evidenced in its newly remodeled Web site and integrated marketing communications materials. Ancillary to its revitalized Web and print presence, a modernized logo reinforces the Algos tagline and reflects the firm's pedigree as a top quality preclinical in vivo pain research specialty organization. The company's new site, marketing literature, and brand identity are the result of a collaboration with MVP Marketing + Design, an award winning marketing communications firm based in Minneapolis, MN.
According to Frank Eichmann, Algos' Director of Marketing, "Our new site helps reposition Algos as the "go-to-CRO" for pain research. Together with other elements of our integrated brand identity, it represents a great step forward in elevating Algos' image and extending our reach to Big Pharma and the medical device manufacturing industry."
Algos plans to officially unveil its new look at the Society for Neuroscience in Chicago from October 17-21, Booth #600.
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy